| A Food and Drug Administration advisory committee voted (18 to 4) Thursday to recommend approval of the new prescription diet drug lorcaserin. It marks the second obesity drug this year that the FDA advisory committee has recommended for approval. See all stories on this topic ยป |
 USA TODAY |
Related Blogs
We LOVE you so.. how about liking us on Facebook?..
Powered By Facebook Like Post Plugin
Leave a Reply